Linzess FDA Approval History
FDA Approved: Yes (First approved August 30, 2012)
Brand name: Linzess
Generic name: linaclotide
Dosage form: Capsules
Company: Allergan plc
Treatment for: Irritable Bowel Syndrome, Constipation, Chronic
Linzess (linaclotide) is a guanylate cyclase-C agonist indicated in adults for treatment of irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC).
Development timeline for Linzess
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.